DK0529065T3 - Receptorbaserede fremgangsmåder til screening for amylinagonister og -antagonister - Google Patents

Receptorbaserede fremgangsmåder til screening for amylinagonister og -antagonister

Info

Publication number
DK0529065T3
DK0529065T3 DK92908951T DK92908951T DK0529065T3 DK 0529065 T3 DK0529065 T3 DK 0529065T3 DK 92908951 T DK92908951 T DK 92908951T DK 92908951 T DK92908951 T DK 92908951T DK 0529065 T3 DK0529065 T3 DK 0529065T3
Authority
DK
Denmark
Prior art keywords
amylin
antagonists
screening
receptor
based methods
Prior art date
Application number
DK92908951T
Other languages
English (en)
Inventor
Kevin Beaumont
Timothy J Rink
Original Assignee
Amylin Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amylin Pharmaceuticals Inc filed Critical Amylin Pharmaceuticals Inc
Application granted granted Critical
Publication of DK0529065T3 publication Critical patent/DK0529065T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
DK92908951T 1991-03-15 1992-03-13 Receptorbaserede fremgangsmåder til screening for amylinagonister og -antagonister DK0529065T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/670,231 US5264372A (en) 1991-03-15 1991-03-15 Receptor-based screening methods for amylin agonists and antagonists
PCT/US1992/002125 WO1992016845A1 (en) 1991-03-15 1992-03-13 Receptor-based screening methods for amylin agonists and antagonists

Publications (1)

Publication Number Publication Date
DK0529065T3 true DK0529065T3 (da) 1999-06-28

Family

ID=24689539

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92908951T DK0529065T3 (da) 1991-03-15 1992-03-13 Receptorbaserede fremgangsmåder til screening for amylinagonister og -antagonister

Country Status (13)

Country Link
US (1) US5264372A (da)
EP (1) EP0529065B1 (da)
JP (1) JPH05508226A (da)
AT (1) ATE172540T1 (da)
AU (1) AU1663092A (da)
CA (1) CA2082929A1 (da)
DE (1) DE69227347T2 (da)
DK (1) DK0529065T3 (da)
IL (5) IL101233A (da)
MX (1) MX9201113A (da)
TW (1) TW324064B (da)
WO (1) WO1992016845A1 (da)
ZA (1) ZA921884B (da)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580953A (en) * 1991-08-14 1996-12-03 Amylin Pharmaceuticals, Inc. Amylin antagonist peptides and uses therefor
DE69333683T2 (de) * 1992-05-15 2005-10-27 Amylin Pharmaceuticals, Inc., San Diego Antikörper-testbesteck zur bestimmung von amylin
AU6249594A (en) * 1993-02-12 1994-08-29 Amylin Pharmaceuticals, Inc. Mcf-7 binding site assays
WO1994021665A1 (en) * 1993-03-24 1994-09-29 Amylin Pharmaceuticals, Inc. Cloned receptors and methods for screening
GB9317193D0 (en) * 1993-08-18 1993-10-06 Zeneca Ltd Method
EP0717635B1 (en) * 1993-09-07 2000-11-15 Amylin Pharmaceuticals, Inc. Methods for regulating gastrointestinal motility
US7115728B1 (en) 1995-01-30 2006-10-03 Ligand Pharmaceutical Incorporated Human peroxisome proliferator activated receptor γ
WO1996031526A1 (en) * 1995-04-06 1996-10-10 Amylin Pharmaceuticals, Inc. Anti-obesity agents
US6143718A (en) 1995-06-07 2000-11-07 Amylin Pharmaceuticals, Inc. Treatment of Type II diabetes mellutis with amylin agonists
US5739106A (en) * 1995-06-07 1998-04-14 Rink; Timothy J. Appetite regulating compositions
ATE417622T1 (de) * 1996-08-08 2009-01-15 Amylin Pharmaceuticals Inc Regulation gastrointestinaler beweglichkeit
US5677279A (en) * 1996-12-16 1997-10-14 Amylin Pharmaceuticals, Inc. Methods and compositions for treating pain with amylin or agonists thereof
AU739020B2 (en) * 1997-01-07 2001-10-04 Amylin Pharmaceuticals, Inc. Use of exendins and agonists thereof for the reduction of food intake
US7101853B2 (en) 1997-05-06 2006-09-05 Amylin Pharmaceuticals, Inc. Method for treating or preventing gastritis using amylin or amylin agonists
US7910548B2 (en) 1997-06-06 2011-03-22 Amylin Pharmaceuticals, Inc. Methods for treating obesity
WO1999005161A1 (en) * 1997-07-25 1999-02-04 Ligand Pharmaceuticals Incorporated HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA (PPARη) GENE REGULATORY SEQUENCES AND USES THEREFOR
US6936584B1 (en) 1998-02-13 2005-08-30 Amylin Pharmaceuticals, Inc. Mixed amylin activity compounds
CA2329513A1 (en) * 1998-05-26 1999-12-02 University Of Medicine And Dentistry Of New Jersey System for reproducing and modulating stability and turnover of rna molecules
US7399489B2 (en) * 1999-01-14 2008-07-15 Amylin Pharmaceuticals, Inc. Exendin analog formulations
KR20070051948A (ko) 1999-01-14 2007-05-18 아밀린 파마슈티칼스, 인크. 글루카곤 억제용 제약학적 조성물
US20030087820A1 (en) * 1999-01-14 2003-05-08 Young Andrew A. Novel exendin agonist formulations and methods of administration thereof
US6924264B1 (en) 1999-04-30 2005-08-02 Amylin Pharmaceuticals, Inc. Modified exendins and exendin agonists
EP1175443A1 (en) 1999-04-30 2002-01-30 Amylin Pharmaceuticals, Inc. Modified exendins and exendin agonists
EP1194778A2 (en) * 1999-07-13 2002-04-10 Amylin Pharmaceuticals, Inc. The use of the area postrema to identify therapeutic compounds
AU2002218218A1 (en) * 2000-10-10 2002-04-22 Austrian Nordic Biotherapeutics Ag A novel system for the evaluation of the activity and/or specificity of a viral component
US20040005997A1 (en) * 2002-06-27 2004-01-08 The Procter & Gamble Company Methods for identifying compounds for regulating muscle mass of function using amylin receptors
WO2004014947A1 (en) * 2002-08-06 2004-02-19 Aventis Pharma Deutschland Gmbh Method for isolating an intestinal cholesterol binding protein
WO2004037168A2 (en) * 2002-10-18 2004-05-06 Amylin Pharmaceuticals, Inc. Treatment of pancreatitis with amylin
US20040214180A1 (en) * 2003-04-28 2004-10-28 Hironori Kobayashi Method and kit for determining quantity of protein
US20070275877A1 (en) * 2003-08-29 2007-11-29 Amylin Pharmaceuticals, Inc. Methods for Treating or Ameliorating Ghrelin-Associated Diseases and Disorders
JP2008500281A (ja) * 2004-02-11 2008-01-10 アミリン・ファーマシューティカルズ，インコーポレイテッド アミリンファミリーペプチドおよびそれらを作成し使用するための方法
US7399744B2 (en) * 2004-03-04 2008-07-15 Amylin Pharmaceuticals, Inc. Methods for affecting body composition
AU2005295043A1 (en) * 2004-10-08 2006-04-20 Amylin Pharmaceuticals, Inc. Amylin family polypeptide-6 (AFP-6) analogs and methods of making and using them
DE102004051014A1 (de) * 2004-10-20 2006-04-27 Rwth Aachen Chemisch modifizierte Peptidanaloga
ES2325773T5 (es) 2004-11-01 2014-02-24 Amylin Pharmaceuticals, Llc. Tratamiento de la obesidad y de los trastornos relacionados
US8394765B2 (en) * 2004-11-01 2013-03-12 Amylin Pharmaceuticals Llc Methods of treating obesity with two different anti-obesity agents
US7879572B2 (en) * 2004-11-12 2011-02-01 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Regulation of F1-ATPase beta subunit cellular location
DE602006016760D1 (de) 2005-03-31 2010-10-21 Amylin Pharmaceuticals Inc Zusammensetzungen und verfahren zur kontrolle, prävention und behandlung von essstörungen
EP1912666A2 (en) * 2005-07-22 2008-04-23 Amylin Pharmaceuticals, Inc. Use of amylin and amylin agonists as cardioprotective or myoprotective agents
WO2009064298A1 (en) * 2007-11-14 2009-05-22 Amylin Pharmaceuticals, Inc. Methods for treating obesity and obesity related diseases and disorders
US9445992B2 (en) 2009-11-25 2016-09-20 Arisgen Sa Mucosal delivery compositions comprising a peptide complexed with a crown compound and/or a counter ion
US9850302B2 (en) 2013-07-12 2017-12-26 Prothena Biosciences Limited Antibodies that recognize IAPP

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4434236A (en) * 1982-10-20 1984-02-28 E. I. Du Pont De Nemours & Co. Immunoassay wherein labeled antibody is displaced from immobilized analyte-analogue
WO1989006135A1 (en) * 1988-01-11 1989-07-13 Amylin Corporation Treatment of type 2 diabetes mellitus
DE69022501T2 (de) * 1989-07-10 1996-02-01 Amylin Pharmaceuticals Inc Verwendung eines Amylinantagonisten zur Herstellung eines Artzneimittels zur Behandlung von Fettsucht und essentieller Hypertonie und damit zusammenhängenden Krankheiten.

Also Published As

Publication number Publication date
EP0529065B1 (en) 1998-10-21
EP0529065A4 (en) 1993-10-20
DE69227347D1 (de) 1998-11-26
TW324064B (en) 1998-01-01
IL120081A0 (en) 1997-04-15
WO1992016845A1 (en) 1992-10-01
EP0529065A1 (en) 1993-03-03
IL101233A (en) 1997-04-15
DE69227347T2 (de) 1999-03-18
IL120082A0 (en) 1997-04-15
AU1663092A (en) 1992-10-21
CA2082929A1 (en) 1992-09-16
US5264372A (en) 1993-11-23
IL101233A0 (en) 1992-11-15
JPH05508226A (ja) 1993-11-18
MX9201113A (es) 1992-10-01
IL120082A (en) 1998-12-27
ATE172540T1 (de) 1998-11-15
ZA921884B (en) 1993-08-03
IL120081A (en) 1998-12-27

Similar Documents

Publication Publication Date Title
DK0529065T3 (da) Receptorbaserede fremgangsmåder til screening for amylinagonister og -antagonister
PT1015608E (pt) Metodos de ensaio de actividade de receptor e construcoes uteis nesses metodos
DK0593618T3 (da) Screeningsassay til påvisning af DNA-bindende molekyler
WO1999024463A3 (en) Signal peptide-containing proteins
ATE408422T1 (de) Methode zur hemmung immunstimulatorischer mit dna assoziierter antworten
ES554795A0 (es) Un metodo de ensayo mejorado para la determinacion de analitos bioligicos tales como haptenos, antigenos ,receptores , farmacos y similares.
ATE262178T1 (de) Identifizierung und charakterisierung von interagierenden molekülen
DK1141237T3 (da) PTH-receptor og screeningsassay der anvender denne
ZA912303B (en) Protein partner screening assays and uses thereof
AR010041A1 (es) Agonistas multifuncionales quimericos de receptores de hematopoyetina
ATE488589T1 (de) Transkriptionaler intermediärfaktor 2
ATE284955T1 (de) Map-kinase: polypeptide, polynukleotide und ihre verwendung
DK0774116T3 (da) Fremgangsmåde til screening af biblioteker af forbindelser
EA199800843A1 (ru) Компьютерный способ создания химических структур, имеющих общие функциональные характеристики
ES2134810T3 (es) Diferenciacion de htlv-i y htlv-ii con la ayuda de peptidos sinteticos.
DK72082A (da) Cytoreceptor-proeve
WO2000018915A3 (en) Membrane-associated organizational proteins
ATE301833T1 (de) Verfahren zum screenen einer die oligomerisierung von rezeptorproteinmolekülen fördernden substanz
TH18474A (th) ลำดับดีเอนเอที่มีรหัสสำหรับหน่วยรับ bmp
NO951250L (no) Amylin-antagonist og fremgangsmåte for screening derav